We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Solvay confirmed that it will start manufacturing sodium bicarbonate at its
Bernburg, Germany site at the end of 2005 -- consequently confirming its position
as a major European and global competitor for the production of this chemical
specialty with exceptional properties.
India's Ranbaxy Laboratories has reported developments in both the UK and the
U.S., receiving FDA approval to make and market a generic version of Proctor
and Gamble's acute cystitis drug Macrobid in the U.S., and settling a dispute
with the UK Department of Health.
Hungarian pharmaceutical company Richter Gedeon Rt. and its Israeli rival Teva
Pharmaceuticals (TEVA) Tuesday joined forces to launch six new generic drugs.
Australian protein therapeutics company EvoGenix Pty Ltd announced a merger
with California-based Absalus Inc. to create an integrated company with a primary
focus on developing new antibody-based drugs.
The Vadodara based specialty
drug manufacturer Sun Pharmaceutical Industries Ltd has decided to merge the
pharmaceutical business of MJ Pharmaceuticals Ltd based at Halol near Vadodara,
into itself.
The Israeli government has secured final legislative approval for
this year's budget increase to the "basket" of drug and healthcare
resources funded by the country's National Health Insurance (NHI) scheme.
The US government has opted to postpone a review into trade benefits
on Brazilian imports, in light of "initial positive steps" by Brazil's
government in combating illicit copying of patented products and drugs.
Russian drug regulator Roszdravnadzor has outlined a further change
to public drug procurement structures, eliminating the requirement to print
price details on pharmaceuticals packets supplied by authorised organisations,
many of which work under a commission agreement.
With the merger of Japanese drugmakers Yamanouchi and Fujisawa now
complete, and with Sankyo and Daiichi also announcing moves to combine operations,
smaller domestic players fear that the new outlook will see them falling behind
local leaders and foreign multinationals.